Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|June 29, 2005
2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2Julius J Matasi, John P Caldwell, Hongtao Zhang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2002
The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonistsGeoffrey B Varty, Mary E Cohen-Williams, Cynthia A Morgan, et al.
Pharmacology, Biochemistry, and Behavior|December 1, 2010
The neurokinin NK2 antagonist, saredutant, ameliorates stress-induced conditions without impairing cognitionNancy Rogacki, Matilde Lopez-Grancha, Vanessa Naimoli, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2006
Cyclobutane derivatives as potent NK1 selective antagonistsMichelle Laci Wrobleski, Gregory A Reichard, Sunil Paliwal, et al.
European Journal of Pharmacology|March 8, 2014
Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behaviorRobert A Hodgson, Deborra Mullins, Sherry X Lu, et al.
Pharmacology, Biochemistry, and Behavior|December 3, 2010
Characterization of the selective mGluR1 antagonist, JNJ16259685, in rodent models of movement and coordinationRobert A Hodgson, Lynn A Hyde, Donald H Guthrie, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2008
Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonistsUnmesh Shah, Claire M Lankin, Craig D Boyle, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2008
Discovery of a novel, potent and orally active series of gamma-lactams as selective NK1 antagonistsSunil Paliwal, Gregory A Reichard, Sapna Shah, et al.
Pageof 4